GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $291,000 | – | 56,915 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $276,000 | 0.10% |
| Geneos Wealth Management Inc. | 445,200 | $725,000 | 0.05% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $20,000 | 0.01% |
| Vivaldi Capital Management LP | 19,261 | $30,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 278,700 | $454,281 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,302,122 | $2,123,000 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $5,632 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $74,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,732 | $34,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 19,255 | $31,000 | 0.00% |